全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

糖皮质激素诱导股骨头坏死发病机制的研究进展
Research Progress on the Pathogenesis of Glucocorticoid-Induced Osteonecrosis of the Femoral Head

DOI: 10.12677/acm.2024.1441146, PP. 1218-1223

Keywords: 糖皮质激素,股骨头坏死,发病机制,综述
Glucocorticoids
, Osteonecrosis of the Femoral Head, Pathogenesis, Review

Full-Text   Cite this paper   Add to My Lib

Abstract:

糖皮质激素作为治疗炎症和免疫性疾病的有效药物被广泛应用,但长期使用可能会导致许多严重的副作用,其中包括股骨头坏死。本文回顾了近年来在糖皮质激素诱导股骨头坏死发病机制方面取得的研究进展。研究发现,糖皮质激素通过增加活性氧产生和氧化应激、损伤内皮细胞和凝血功能、调节脂质代谢、影响细胞凋亡和自噬以及干扰非编码RNA的调控等途径参与股骨头坏死的发生发展。
Glucocorticoids are widely used as effective medications for the treatment of inflammatory and immune disorders, but prolonged use can lead to many serious side effects, including osteonecrosis of the femoral head. This article reviews the research progress made in recent years in the pathogenesis of glucocorticoid-induced osteonecrosis of the femoral head. It was found that glucocorticoids are involved in the development of osteonecrosis of the femoral head by increasing reactive oxygen species production and oxidative stress, damaging endothelial cells and coagulation, regulating lipid metabolism, affecting apoptosis and autophagy, as well as interfering with the regulation of non-coding RNAs.

References

[1]  Zhao, D., Zhang, F., Wang, B., et al. (2020) Guidelines for Clinical Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults (2019 Version). Journal of Orthopaedic Translation, 21, 100-110.
https://doi.org/10.1016/j.jot.2019.12.004
[2]  Huang, C., Qing, L., Xiao, Y., et al. (2023) Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells. Biomolecules, 14, Article 4.
https://doi.org/10.3390/biom14010004
[3]  Hines, J.T., Jo, W.L., Cui, Q., et al. (2021) Osteonecrosis of the Femoral Head: An Updated Review of ARCO on Pathogenesis, Staging and Treatment. Journal of Korean Medical Science, 36, e177.
https://doi.org/10.3346/jkms.2021.36.e177
[4]  Scherholz, M.L., Schlesinger, N. and Androulakis, I.P. (2019) Chronopharmacology of Glucocorticoids. Advanced Drug Delivery Reviews, 151-152, 245-261.
https://doi.org/10.1016/j.addr.2019.02.004
[5]  Timmermans, S., Souffriau, J. and Libert, C. (2019) A General Introduction to Glucocorticoid Biology. Frontiers in Immunology, 10, Article 1545.
https://doi.org/10.3389/fimmu.2019.01545
[6]  Tan, G., Kang, P.D. and Pei, F.X. (2012) Glucocorticoids Affect the Metabolism of Bone Marrow Stromal Cells and Lead to Osteonecrosis of the Femoral Head: A Review. Chinese Medical Journal, 125, 134-139.
[7]  Wang, L., Lu, Z., Zhao, J., et al. (2021) Selective Oxidative Stress Induces Dual Damage to Telomeres and Mitochondria in Human T Cells. Aging Cell, 20, e13513.
https://doi.org/10.1111/acel.13513
[8]  Tolba, M.F., El-Serafi, A.T. and Omar, H.A. (2017) Caffeic Acid Phenethyl Ester Protects against Glucocorticoid-Induced Osteoporosis in Vivo: Impact on Oxidative Stress and RANKL/OPG Signals. Toxicology and Applied Pharmacology, 324, 26-35.
https://doi.org/10.1016/j.taap.2017.03.021
[9]  Chen, J., Cui, Z., Wang, Y., et al. (2022) Cyclic Polypeptide D7 Protects Bone Marrow Mesenchymal Cells and Promotes Chondrogenesis during Osteonecrosis of the Femoral Head via Growth Differentiation Factor 15-Mediated Redox Signaling. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 3182368.
https://doi.org/10.1155/2022/3182368
[10]  Yang, N., Sun, H., Xue, Y., et al. (2021) Inhibition of MAGL Activates the Keap1/Nrf2 Pathway to Attenuate Glucocorticoid-Induced Osteonecrosis of the Femoral Head. Clinical and Translational Medicine, 11, e447.
https://doi.org/10.1002/ctm2.447
[11]  Zuo, W., Guo, W.S., Yu, H.C., et al. (2020) Role of Junction-Mediating and Regulatory Protein in the Pathogenesis of Glucocorticoid-Induced Endothelial Cell Lesions. Orthopaedic Surgery, 12, 964-973.
https://doi.org/10.1111/os.12680
[12]  Salhotra, A., Shah, H.N., Levi, B., et al. (2020) Mechanisms of Bone Development and Repair. Nature Reviews Molecular Cell Biology, 21, 696-711.
https://doi.org/10.1038/s41580-020-00279-w
[13]  Yu, H., Liu, P., Zuo, W. and Longaker, M.T. (2020) Decreased Angiogenic and Increased Apoptotic Activities of Bone Microvascular Endothelial Cells in Patients with Glucocorticoid-Induced Osteonecrosis of the Femoral Head. BMC Musculoskeletal Disorders, 21, Article No. 277.
https://doi.org/10.1186/s12891-020-03225-1
[14]  Zhang, Q., Li, T., Li, Z., et al. (2022) Autocrine Activity of Extracellular Vesicles Induced by Icariin and Its Effectiveness in Glucocorticoid-Induced Injury of Bone Microvascular Endothelial Cells. Cells, 11, Article 1921.
https://doi.org/10.3390/cells11121921
[15]  Kim, T.H., Baek, S.H., Lim, J.O., et al. (2015) Genetic Variation in the Coagulation Factor V Gene and Risk of Femoral Head Osteonecrosis. Molecular Medicine Reports, 12, 4434-4440.
https://doi.org/10.3892/mmr.2015.4000
[16]  Zhang, Y., Yin, J., Ding, H., et al. (2016) Vitamin K2 Ameliorates Damage of Blood Vessels by Glucocorticoid: A Potential Mechanism for Its Protective Effects in Glucocorticoid-Induced Osteonecrosis of the Femoral Head in a Rat Model. International Journal of Biological Sciences, 12, 776-785.
https://doi.org/10.7150/ijbs.15248
[17]  Chan, K.L. and Mok, C.C. (2012) Glucocorticoid-Induced Avascular Bone Necrosis: Diagnosis and Management. The Open Orthopaedics Journal, 6, 449-457.
https://doi.org/10.2174/1874325001206010449
[18]  Wang, X.Y., Ma, T.L., Chen, K.N., et al. (2021) Accumulation of LDL/Ox-LDL in the Necrotic Region Participates in Osteonecrosis of the Femoral Head: A Pathological and in Vitro Study. Lipids in Health and Disease, 20, Article No. 167.
https://doi.org/10.1186/s12944-021-01601-x
[19]  Yuan, L., Li, W., Wang, X., et al. (2018) The Relationship Between Genetic Polymorphisms in Apolipoprotein E (ApoE) Gene and Osteonecrosis of the Femoral Head Induced by Steroid in Chinese Han Population. Genes & Genomics, 40, 225-231.
https://doi.org/10.1007/s13258-017-0625-5
[20]  Yan, Y., Wang, J., Huang, D., et al. (2022) Plasma Lipidomics Analysis Reveals Altered Lipids Signature in Patients with Osteonecrosis of the Femoral Head. Metabolomics, 18, Article No. 14.
https://doi.org/10.1007/s11306-022-01872-0
[21]  Jiang, Y., Zhang, Y., Zhang, H., et al. (2014) Pravastatin Prevents Steroid-Induced Osteonecrosis in Rats by Suppressing PPARγ Expression and Activating Wnt Signaling Pathway. Experimental Biology and Medicine, 239, 347-355.
https://doi.org/10.1177/1535370213519215
[22]  Jiang, Y., Zhang, Y., Chen, W., et al. (2014) Achyranthes Bidentata Extract Exerts Osteoprotective Effects on Steroid-Induced Osteonecrosis of the Femoral Head in Rats by Regulating RANKL/RANK/OPG Signaling. Journal of Translational Medicine, 12, Article No. 334.
https://doi.org/10.1186/s12967-014-0334-7
[23]  Tao, S.C., Yuan, T., Rui, B.Y., et al. (2017) Exosomes Derived from Human Platelet-Rich Plasma Prevent Apoptosis Induced by Glucocorticoid-Associated Endoplasmic Reticulum Stress in Rat Osteonecrosis of the Femoral Head Via the Akt/Bad/Bcl-2 Signal Pathway. Theranostics, 7, 733-750.
https://doi.org/10.7150/thno.17450
[24]  Nie, Z., Chen, S. and Peng, H. (2019) Glucocorticoid Induces Osteonecrosis of the Femoral Head in Rats through GSK3β-Mediated Osteoblast Apoptosis. Biochemical and Biophysical Research Communications, 511, 693-699.
https://doi.org/10.1016/j.bbrc.2019.02.118
[25]  Jia, D., O’Brien, C.A., Stewart, S.A., et al. (2006) Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density. Endocrinology, 147, 5592-5599.
https://doi.org/10.1210/en.2006-0459
[26]  Jia, J., Yao, W., Guan, M., et al. (2011) Glucocorticoid Dose Determines Osteocyte Cell Fate. FASEB Journal, 25, 3366-3376.
https://doi.org/10.1096/fj.11-182519
[27]  Wang, X.Y., Gong, L.J., Huang, J.M., et al. (2020) Pinocembrin Alleviates Glucocorticoid-Induced Apoptosis by Activating Autophagy via Suppressing the PI3K/Akt/MTOR Pathway in Osteocytes. European Journal of Pharmacology, 880, Article ID: 173212.
https://doi.org/10.1016/j.ejphar.2020.173212
[28]  Han, Y., Zhang, L., Xing, Y., et al. (2018) Autophagy Relieves the Function Inhibition and Apoptosis-Promoting Effects on Osteoblast Induced by Glucocorticoid. International Journal of Molecular Medicine, 41, 800-808.
https://doi.org/10.3892/ijmm.2017.3270
[29]  Liu, T., Cao, Y., Han, C., et al. (2021) Association of MIR17HG and MIR155HG Gene Variants with Steroid-Induced Osteonecrosis of the Femoral Head in the Population of Northern China. Journal of Orthopaedic Surgery and Research, 16, Article No. 673.
https://doi.org/10.1186/s13018-021-02669-y
[30]  Xue, F., Wu, J., Feng, W., et al. (2022) MicroRNA-141 Inhibits the Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells in Steroid-Induced Osteonecrosis via E2F3. Molecular Medicine Reports, 26, Article No. 234.
https://doi.org/10.3892/mmr.2022.12750
[31]  Li, Z., Jiang, C., Ye, C., et al. (2018) MiR-10a-5p, MiR-99a-5p and MiR-21-5p Are Steroid-Responsive Circulating MicroRNAs. American Journal of Translational Research, 10, 1490-1497.
[32]  Xiang, S., Li, Z. and Weng, X. (2019) The Role of LncRNA RP11-154D6 in Steroid-Induced Osteonecrosis of the Femoral Head through BMSC Regulation. Journal of Cellular Biochemistry, 120, 18435-18445.
https://doi.org/10.1002/jcb.29161
[33]  Wu, Y., Fang, L., Gao, Y., et al. (2022) LncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting MiR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head. Journal of Healthcare Engineering, 2022, Article ID: 9364467.
https://doi.org/10.1155/2022/9364467
[34]  Feng, X., Xiang, Q., Jia, J., et al. (2022) CircHGF Suppressed Cell Proliferation and Osteogenic Differentiation of BMSCs in ONFH Via Inhibiting MiR-25-3p Binding to SMAD7. Molecular Therapy Nucleic Acids, 28, 99-113.
https://doi.org/10.1016/j.omtn.2022.02.017
[35]  Peng, P., He, W., Zhang, Y.X., et al. (2023) CircHIPK3 Promotes Bone Microvascular Endothelial Cell Proliferation, Migration and Angiogenesis by Targeting MiR-7 and KLF4/VEGF Signaling in Steroid-Induced Osteonecrosis of the Femoral Head. Advances in Clinical and Experimental Medicine, 32, 43-55.
https://doi.org/10.17219/acem/153042

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133